SKIN The Journal of Cutaneous Medicine

The Anti-Inflammatory Properties of Ivermectin and Brimonidine in the Treatment of Papulopustular Rosacea

Linda Stein Gold, Edward Lain, Alison Harvey

Page s59

Poster PDF

Association between Rosacea, Environmental Factors, and Facial Cutaneous Dysbiosis

Justin W. Marson, Stefano Berto, Paul Mouser, Hilary E. Baldwin

Page 487-495

PDF Supplement PDF KOL SUMMARY

Consistent Efficacy and Safety in Four Double-Blind, Vehicle-Controlled Studies of Ivermectin 1% Cream in the Treatment of Moderate-to-Severe Papulopustular Rosacea

Linda Stein Gold, JP York, Jean Jacovella

Page s61

Poster PDF

Concurrent Administration of Ivermectin 1% Cream with Brimonidine 0.33% Gel Improves Efficacy and Tolerability in the Treatment of Moderate-to-Severe Rosacea

Linda Stein Gold, Kim Papp, Charles Lynde, Edward Lain, Melinda Gooderham, Sandra Johnson, Nabil Kerrouche, Gregor Schafer

Page s60

Poster PDF

Topical Minocycline Foam (FMX-103) for the Treatment of Moderate-to-Severe Rosacea: Results of a Phase 2, Randomized, Double-Blind, Multicenter Clinical Study

Ulrich Mrowietz, Tal Hetzroni Kedem, Rita Kenyan, Meir Eini, Dov Tamarkin, Mitchell Shirvan

Page s63

Poster PDF

DFD 29, a low dose oral minocycline, shows significant improvement in quality of life in subjects with papulopustular rosacea

Linda Stein Gold, Joshua Zeichner, Shanavas Alikunju, Anirudh Gautam, Srinivas Shenoy, Preeti Singh, Srinivas Sidgiddi

Page S10

Poster PDF

Achieving an Endpoint of Completely Clear of Inflammatory Lesions and Erythema After Treatment of Rosacea Provides Multiple Positive Patient Outcomes: A Pooled Analysis

Guy Webster, Martin Schaller, Jerry Tan, Mark Jackson, Nabil Kerrouche, Gregor Schafer

Page s58

Poster PDF

Early Onset of Efficacy Using a 1% and 2% Topical Minocycline Gel for the Treatment of Rosacea: a Small Open Label Study

N Bhatia, M Ahmadyar, H Hansra, J Del Rosso, H Baldwin, AM Daniels

Page S35

Poster PDF

Patient Concerns and Treatment Satisfaction in Patients Treated with Azelaic Acid Foam for Rosacea

T Williamson, J Cameron, K McLeod, B Turner, A Quillen, A LaRose

Page S36

Poster PDF

DFD-29, a low dose oral minocycline, demonstrates superior efficacy as compared to placebo and Oraycea ® Capsules (doxycycline HCl) in subjects with papulopustular rosacea

Athanasios Tsianakas, Neal Bhatia, Shanavas Alikunju, Anirudh Gautam, Srinivas Shenoy, Preeti Singh, Srinivas Sidgiddi

Page S11

Poster PDF

Antibiotic Resistance Considerations of Importance to Clinical Dermatologists

James Del Rosso

Page 64-73

Full Article PDF

Evaluation of the Safety and Efficacy of Ultherapy for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea

Rosalyn George, Joel Schlessinger, Mark Lupin, David Amato, David McDaniel

Page s62

Poster PDF

Truncal Demodex Folliculitis

Timothy Jay Orlowski, Hoyt Harris Reynolds, Lauren V Graham

Page 365-368

PDF

Pharmacokinetics of Minocycline Foam FMX103 in Subjects With Moderate-to-Severe Facial Papulopustular Rosacea Under Maximum-Use Conditions: Results of a Phase 1 Study

Terry Jones, Iain Stuart

Page 162

Poster PDF

Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies

Linda Stein Gold, James Q Del Rosso, Neal D Bhatia, et al.

Page 161

Poster PDF

Evolution of a Doxycycline-Induced Phototoxic Rash With an Unusual Distribution

Katrina Kesterson, Adrian Subrt, Michael Wilkerson

Page 236-239

Full Article PDF

Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide

James Del Rosso, Neal Bhatia, Hilary Baldwin, Linda Stein Gold, Seemal Desai, Sam Brantman

Page s15

Poster PDF

Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea

Neal Bhatia, Edward Lain, Hilary Baldwin, Sam Brantman, James Del Rosso, Raja Sivamani

Page s14

Poster PDF

Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study Evaluating Efficacy and Safety

James Del Rosso, Leon Kircik, Cheryl Effron, Zoe Draelos

Page s72

Poster PDF

Effect of Combination Therapy on Visible/Non-Visible Symptoms, and Disease Burden Associated with Severe Rosacea: Results from A Post-Hoc Analysis of A Randomized Controlled Trial

James Q Del Rosso, Mark Jackson, Sandra Johnson, Alison Harvey, Rajeev Chavda

Page s56

Poster PDF

Angiosarcoma Clinically Mimicking a Targetoid Hemosiderotic Hemangioma

Hannah Nam, Jordan Lim, Alexandra Flamm

Page 422-425

PDF

2nd Place: Acne Vulgaris and the Facial Cutaneous Microbiome

Justin W. Marson, Paul Mouser, Stefano Berto, Hilary Baldwin

Page s33

Poster PDF

Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea

Linda Stein Gold, James Q Del Rosso, Leon Kircik, Neal D Bhatia, Deirdre Hooper, Walter Nahm, Iain Stuart

Page s54

Poster PDF

Apremilast as an Off-Label Therapeutic Agent

Justin W. Marson, Mark Lebwohl

Page 203-227

PDF KOL SUMMARY

Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies

James Q Del Rosso, Linda Stein Gold, Leon Kircik, Neal D Bhatia, Neil Sadick, Matthew Zirwas, Edward Lain, Iain Stuart

Page s55

Poster PDF

Search

Search Results